Pegdinetanib Unknown Status Phase 2 Trials for Recurrent Glioblastoma Multiforme / Brain and Central Nervous System Tumors Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00562419CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan